Genome-wide association studies in Alzheimer's disease: A review topical collection on dementia

93Citations
Citations of this article
53Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Over the past decade, research aiming to disentangle the genetic underpinnings of late-onset Alzheimer's disease has mostly focused on the identification of common variants through genome-wide association studies. The identification of several new susceptibility genes through these efforts has reinforced the importance of amyloid precursor protein and tau metabolism in the cause of the disease and has implicated immune response, inflammation, lipid metabolism, endocytosis/intracellular trafficking, and cell migration in the cause of the disease. Ongoing and future large-scale genome-wide association studies, translational studies, and next-generation whole genome or whole exome sequencing efforts, hold the promise to map the specific causative variants in these genes, to identify several additional risk variants, including rare and structural variants, and to identify novel targets for genetic testing, prevention, and treatment. © 2013 Springer Science+Business Media New York.

Cite

CITATION STYLE

APA

Tosto, G., & Reitz, C. (2013, October 1). Genome-wide association studies in Alzheimer’s disease: A review topical collection on dementia. Current Neurology and Neuroscience Reports. Current Medicine Group LLC 1. https://doi.org/10.1007/s11910-013-0381-0

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free